Azithromycin non-susceptible Shigella circulating in Israel, 2014–2016

Shigella species remains a major diarrhoeagenic agent, affecting mostly children, with global high incidence and high mortality rate specially in developing areas. Although azithromycin is recommended for treatment of shigellosis, there are currently no CLSI susceptibility breakpoints, accordingly n...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezernitchi, Analía V., Sirotkin, Elizabeta, Danino, Dana, Agmon, Vered, Valinsky, Lea, Rokney, Assaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799884/
https://www.ncbi.nlm.nih.gov/pubmed/31626667
http://dx.doi.org/10.1371/journal.pone.0221458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799884/
https://www.ncbi.nlm.nih.gov/pubmed/31626667
http://dx.doi.org/10.1371/journal.pone.0221458

Ejemplares similares